日本重症监护病房呼吸机相关肺炎的临床和经济影响

IF 1.8 Q3 INFECTIOUS DISEASES

Infection Prevention in Practice Pub Date : 2025-01-21 DOI:10.1016/j.infpip.2025.100440

Taikan Nanao , Koichi Benjamin Ishikawa , Shunya Ikeda , Tsutomu Yamazaki

{"title":"日本重症监护病房呼吸机相关肺炎的临床和经济影响","authors":"Taikan Nanao , Koichi Benjamin Ishikawa , Shunya Ikeda , Tsutomu Yamazaki","doi":"10.1016/j.infpip.2025.100440","DOIUrl":null,"url":null,"abstract":"<div><div>Ventilator-associated pneumonia (VAP) has a considerable impact on both clinical outcomes and healthcare costs. This study compared 40 patients having VAP with 40 matched controls from a Japanese ICU dataset. Patients with VAP experienced significantly longer ICU and hospital stays, fewer ventilator-free days, and a higher incidence of tracheostomies. VAP cases also required more broad-spectrum antimicrobials, leading to an additional cost of approximately USD 24,410 per case. These results highlight the importance of implementing effective infection control strategies to mitigate VAP's clinical and economic consequences.</div></div>","PeriodicalId":33492,"journal":{"name":"Infection Prevention in Practice","volume":"7 1","pages":"Article 100440"},"PeriodicalIF":1.8000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical and economic impact of ventilator-associated pneumonia in intensive care units in Japan\",\"authors\":\"Taikan Nanao , Koichi Benjamin Ishikawa , Shunya Ikeda , Tsutomu Yamazaki\",\"doi\":\"10.1016/j.infpip.2025.100440\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Ventilator-associated pneumonia (VAP) has a considerable impact on both clinical outcomes and healthcare costs. This study compared 40 patients having VAP with 40 matched controls from a Japanese ICU dataset. Patients with VAP experienced significantly longer ICU and hospital stays, fewer ventilator-free days, and a higher incidence of tracheostomies. VAP cases also required more broad-spectrum antimicrobials, leading to an additional cost of approximately USD 24,410 per case. These results highlight the importance of implementing effective infection control strategies to mitigate VAP's clinical and economic consequences.</div></div>\",\"PeriodicalId\":33492,\"journal\":{\"name\":\"Infection Prevention in Practice\",\"volume\":\"7 1\",\"pages\":\"Article 100440\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-01-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infection Prevention in Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590088925000046\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection Prevention in Practice","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590088925000046","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

摘要

呼吸机相关性肺炎（VAP）对临床结果和医疗保健费用都有相当大的影响。本研究比较了来自日本ICU数据集的40名VAP患者和40名匹配的对照组。VAP患者的ICU和住院时间明显更长，无呼吸机天数更少，气管切开术发生率更高。VAP病例还需要更多的广谱抗微生物药物，导致每例病例的额外费用约为24,410美元。这些结果强调了实施有效的感染控制策略以减轻VAP的临床和经济后果的重要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Clinical and economic impact of ventilator-associated pneumonia in intensive care units in Japan

Ventilator-associated pneumonia (VAP) has a considerable impact on both clinical outcomes and healthcare costs. This study compared 40 patients having VAP with 40 matched controls from a Japanese ICU dataset. Patients with VAP experienced significantly longer ICU and hospital stays, fewer ventilator-free days, and a higher incidence of tracheostomies. VAP cases also required more broad-spectrum antimicrobials, leading to an additional cost of approximately USD 24,410 per case. These results highlight the importance of implementing effective infection control strategies to mitigate VAP's clinical and economic consequences.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Infection Prevention in Practice Medicine-Public Health, Environmental and Occupational Health

CiteScore

4.80

自引率

0.00%

发文量

审稿时长

61 days